gvtcx

Whole Genome Sequencing

UK Biobank Ltd Published 26 Jan 2018 Contracts Finder

key details

Value£30,000,000
Statuscomplete
Category (CPV) 85148000
RegionNorth West
Deadline27 Feb 2018
Contract start30 Mar 2018
Contract end31 Mar 2021
Procedureopen
SME suitableNo
OCIDocds-b5fd17-5a531839-e50c-41c4-b024-e1515d055fba

Award

SupplierValueDateStatus
Genome Research Ltd £27,400,000 15 Mar 2018 active

description

UK Biobank requires a sequencing provider that can offer Whole Genome Sequencing (WGS) services that meet the requirements outlined in this specification.

The key parameters for any bidder are as follows:

There is up to £30m funding available for a vanguard phase of whole genome sequencing;
The scope of the tender is for sequencing (and certain named ancillary) services only;
The sequencing for this vanguard phase should ideally be completed by the end of 2019 (see section 1.2.1 for preferred timetable).

Additional information: UK Biobank is issuing this tender to invite Bids to conduct a vanguard phase of whole genome sequencing. The principal purpose of this vanguard phase is to inform and develop the protocols and processes for the whole genome sequencing of all UK Biobank's 500,000 participants which is expected to take place (subject to confirmation of funding) and complete in the next five years.

UK Biobank is a major national health resource, and a registered charity in its own right, with the aim of improving the prevention, diagnosis and treatment of a wide range of serious and life-threatening illnesses - including cancer, heart diseases, stroke, diabetes, arthritis, osteoporosis, eye disorders, depression and forms of dementia.

UK Biobank recruited 500,000 people aged between 40-69 years in 2006-2010 from across the country to take part in this project. They have undergone measures, provided blood, urine and saliva samples for future analysis, given detailed information about themselves and agreed to have their health followed. Over many years this is building into a powerful resource to help scientists discover why some people develop particular diseases and others do not.

We have uploaded to the portal a revised version of the tender documents today 5/2/18. We have had to make minor amendments to the tender documents originally uploaded on 26/1/18. The changes - in wording of the specification in sections 1.4 and 4, which is reflected in the response questions, and to the weightings - are highlighted in the ITT which can be found attached to this notice .

Please ensure you use the revised version of the ITT dated 5.2.18 when preparing your tender response. It should be noted that the timetable for tender returns remains unchanged.

We apologise for having to make changes, and if you have any questions following this please contact us using the details in the tender pack

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
11 May 2018 Award (award) · 9e532d89-e9e4-4264-9046-3662a0398fec-215528

more from UK Biobank Ltd

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.